Insider Trading April 17, 2026 09:19 AM

Trustee Charles Gerber Buys $30,080 of Credit Suisse High Yield Fund Shares

Purchase coincides with fund trading near its 52-week low as UBS advances Credit Suisse migration plan

By Ajmal Hussain DHY
Trustee Charles Gerber Buys $30,080 of Credit Suisse High Yield Fund Shares
DHY

Charles Gerber, a trustee of the Credit Suisse High Yield Credit Fund (NYSE: DHY), purchased 16,000 common shares on April 16, 2026, at $1.88 per share for a total of $30,080. The transaction comes while DHY trades about 3% above its 52-week low, with a market capitalization near $195 million and a dividend yield of 9.89%. Separately, UBS reports it is close to completing the migration of former Credit Suisse clients onto its platform, with one event remaining and a shutdown of Credit Suisse systems planned to begin at the end of March and conclude by the end of 2026.

Key Points

  • Charles Gerber, a trustee of Credit Suisse High Yield Credit Fund (NYSE: DHY), bought 16,000 shares on April 16, 2026, at $1.88 per share for $30,080.
  • DHY is trading about 3% above its 52-week low of $1.82, has a market cap of approximately $195 million, and offers a 9.89% dividend yield.
  • UBS is near completion of migrating former Credit Suisse clients, with one migration event remaining; system shutdowns start end of March and the full process is expected to finish by end of 2026.

Charles Gerber, serving as a trustee for the Credit Suisse High Yield Credit Fund (NYSE: DHY), executed a purchase of 16,000 common shares on April 16, 2026. The buy was completed at $1.88 per share, resulting in a total reported transaction value of $30,080.

At the time of the transaction the fund was trading roughly 3% above its 52-week low of $1.82. DHY carries a market capitalization near $195 million and offers a reported dividend yield of 9.89%.

Information from InvestingPro, which tracks the fund, indicates DHY has continued to pay dividends for 29 consecutive years. That metric was highlighted alongside the trustee purchase and the fund’s pricing and yield profile.


In related developments involving the broader Credit Suisse integration, UBS said it is nearing the final steps of migrating former Credit Suisse clients onto its own systems. Switzerland Country Head Sabine Keller-Busse was quoted as saying only one event remains in the migration process.

UBS plans to begin shutting down Credit Suisse systems at the end of March, with the full migration and shutdown process expected to be completed by the end of 2026. The bank has characterized the work as part of ongoing efforts to integrate Credit Suisse operations, streamline systems, and improve operational efficiency.

Those integration milestones and the size of the project have drawn investor attention because of the scale and potential impact on market participants connected to Credit Suisse and UBS operations.


The trustee purchase, the fund’s valuation metrics, its long dividend history as reported by InvestingPro, and the UBS migration timeline together form the factual basis for monitoring DHY and related market developments. Investors and market observers are noted in the reporting as closely watching these changes given their scale and potential market relevance.

Risks

  • Market pricing risk - DHY is trading close to its 52-week low, which may indicate limited near-term price resilience in the fund.
  • Timeline uncertainty - The UBS migration has a stated completion target by the end of 2026 and one remaining event, leaving the exact timing subject to the schedule outlined by the bank.
  • Integration scale and operational impact - The size and complexity of consolidating Credit Suisse operations into UBS are described as significant, creating ongoing monitoring needs for investors.

More from Insider Trading

OrbiMed Expands Stake in Traws Pharma via Strategic Private Placement Apr 28, 2026 Rexford Industrial Realty General Counsel Completes $1.18 Million Stock Sale Apr 28, 2026 Bicara Therapeutics CMO Executes Rule 10b5-1 Trading Plan Involving Share Sales and Option Exercises Apr 28, 2026 Abbott Laboratories Director Daniel Starks Executes Substantial Open Market Share Purchase Apr 28, 2026 BlackRock President Robert Kapito Executes $9.2 Million Share Sale Apr 28, 2026